Research Area
Immunogenicity Testing Services
Your Trusted Partner for Immunogenicity Testing
Immunogenicity plays a crucial role in therapeutic development, especially for biologics, where unwanted immune responses can impact patient safety and treatment efficacy. Detecting potential immunogenic risks early is essential for reducing patient risk and ensuring therapeutic success.
BIOQUAL provides immunogenicity testing services to support vaccine immunogenicity testing, therapeutic development and preclinical research programmes. Our scientists combine validated assays, immune profiling and in vivo and in vitro capabilities to evaluate humoral and cellular immune responses across a range of study types.
Immunogenicity Testing Capabilities
BIOQUAL offers a full range of immunogenicity testing services to assess the potential immunogenicity of therapeutics including proteins, antibodies, gene therapies and cell therapies.
Don’t see the assay or model you need? Contact us to discuss your unique requirements—our team is committed to developing tailored solutions to meet your specific research goals.
Immunogenicity Studies in Animal Models
We provide a diverse range of animal models for vaccine immunogenicity testing, enabling precise evaluation of immune responses and vaccine efficacy. Our models are tailored to meet the unique demands of vaccine research, ensuring high-quality data to drive development forward.
Neutralizing Antibody (NAb) Assays
Neutralizing antibodies play a critical role in immunity by blocking the activity of pathogens. Our NAb assays—available in cell-based and competitive ligand-binding formats—are designed to detect antibodies that neutralize pathogens with precision, supporting the development of effective and safe therapies.
Immune Response Profiling
We offer comprehensive immune profiling services, including binding antibody and humoral responses, T-cell analysis, and cytokine response analysis, to uncover insights into immune response mechanisms. This profiling provides a deeper understanding of immunogenic pathways, aiding in the refinement of therapeutic strategies.
Custom Immunogenicity Assay Development
BIOQUAL’s team works closely with clients to develop and validate customized assays tailored to their specific biologic and therapeutic goals. Whether your needs call for ELISA, Luminex, ELISpot or flow cytometry, we offer an array of advanced assay platforms to ensure high-quality, reproducible data. Our platform flexibility allows us to adapt our methods to your unique research requirements.
Advanced Laboratory Capabilities
BIOQUAL’s advanced laboratory capabilities support immunogenicity testing, immune profiling and complex preclinical research while meeting rigorous safety and quality standards:
Biosafety Levels and Facilities
Our labs operate up to BSL-3 with select agent standards, ensuring the safe handling of highly infectious agents.
State-of-the-Art Technology
From immunoassays to advanced imaging, BIOQUAL’s technology stack supports complex research needs with precision.
Quality and Compliance
We are AAALAC-accredited and can run regulatory-compliant experiments for high-stakes preclinical studies and IND submissions.
